Australia's most trusted
source of pharma news
Thursday, 16 April 2026
Posted 15 April 2026 PM
An ASX-listed company has announced the surprise resignation of its CEO, and the immediate appointment of a successor.
In a statement to the ASX yesterday Sydney-based Noxopharm announced the resignation of CEO Dr Gisela Mautner, who took over the job from founder Graham Kelly in 2022.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.